
浏览全部资源
扫码关注微信
1.上海中医药大学附属龙华医院肛肠科,上海 200032
2.上海市第六人民医院中医科,上海 200032
张嘉员,Email:jiayuan5267@foxmail.com,研究方向:中医药治疗肛肠疾病的临床及基础研究。
姚一博,Email:elevenzoe@163.com。
收稿:2024-07-26,
修回:2024-11-14,
纸质出版:2026-01-28
移动端阅览
张嘉员,陆金根,王钱陶等.肛周会阴部坏死性筋膜炎病原菌分布及耐药性分析[J].重庆医科大学学报,2026,51(01):109-114.
Zhang Jiayuan,Lu Jingen,Wang Qiantao,et al.Pathogen distribution and drug resistance in patients with Fournier’s gangrene[J].Journal of Chongqing Medical University,2026,51(01):109-114.
张嘉员,陆金根,王钱陶等.肛周会阴部坏死性筋膜炎病原菌分布及耐药性分析[J].重庆医科大学学报,2026,51(01):109-114. DOI: 10.13406/j.cnki.cyxb.003726.
Zhang Jiayuan,Lu Jingen,Wang Qiantao,et al.Pathogen distribution and drug resistance in patients with Fournier’s gangrene[J].Journal of Chongqing Medical University,2026,51(01):109-114. DOI: 10.13406/j.cnki.cyxb.003726.
目的
2
分析肛周会阴部坏死性筋膜炎患者致病菌分布及其药敏试验结果,为重症感染性疾病合理使用抗生素方案提供依据。
方法
2
回顾性分析2015年1月至2022年6月上海中医药大学附属龙华医院肛肠科收治肛周会阴部坏死性筋膜炎患者64例,统计患者的临床资料、病原菌培养结果和药敏试验结果。
结果
2
64例微生物送检报告中,未见病原菌生长12例,病原菌生长52例,共培养出79株致病菌。致病菌以革兰阴性菌为主,2种优势菌为大肠埃希菌(25/79,31.65%)和肺炎克雷伯菌(22/79,27.85%)。药敏试验结果显示,革兰阳性菌对青霉素G耐药率高达78.57%,对万古霉素敏感率为100%;革兰阴性菌对氨苄西林、头孢曲松、复方新诺明、左氧氟沙星、氨苄西林-舒巴坦的耐药率高于50%,对亚胺培南、美罗培南和阿米卡星的敏感性较高。分析病原菌种类与死亡率、住院时间和Fournier坏疽严重程度指数(Fournier’s gangrene severity index,FGSI)的相关性,发现混合菌组比革兰阴性菌组住院时间增加4.287 d,但病原菌种类与死亡率和FGSI评分无相关性。
结论
2
肛周会阴部坏死性筋膜炎感染以革兰阴性菌为主,早期足量使用碳青霉烯类、糖肽类联合硝基咪唑类抗生素可以达到更高的病原菌覆盖率。病原菌对常见抗生素的敏感性较低,耐药菌株种类和数量较以往报道有所增加,临床上应规范抗菌药物的使用,降低耐药菌株产生。
Objective
2
To investigate the distribution of pathogens and the results of drug sensitivity test in patients with Fournier’s gangrene(FG),and to provide a basis for rational use of antibiotics in the treatment of severe infectious diseases.
Methods
2
A retrospective analysis was performed for the data of 64 patients with FG who were admitted to Department of Anorectal Surgery,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,from January 2015 to June 2022,including clinical data and the results of bacterial culture and drug sensitivity test.
Results
2
Among the 64 microbial test reports,there were 12 cases without pathogen growth and 52 cases with pathogen growth,and a total of 79 pathogenic strains were isolated. Most pathogenic bacteria were Gram-negative bacteria,with two dominant bacteria of
Escherichia coli
(25/79,31.65%) and
Klebsiella pneumoniae
(22/79,27.85%). The results of drug sensitivity test showed that the resistance rate of Gram-positive bacteria to penicillin G reached as high as 78.57%,with a sensitivity rate of 100% to vancomycin; Gram-negative bacteria had a resistance rate of
>
50% to ampicillin,ceftriaxone,sulfamethoxazole-trimethoprim,levofloxacin,and ampicillin-sulbactam,with a relatively high sensitivity to imipenem,meropenem,and amikacin. By analyzing the correlation of the types of pathogens with mortality rate,length of hospital stay,and Fournier’s Gangrene Severity Index(FGSI) score,it was found that the length of hospital stay in the mixed bacterial infection group was 4.287
days longer than that in the Gram-negative bacterial infection group,while the types of pathogens were not correlated with mortality rate or FGSI score.
Conclusion
2
FG is mainly caused by Gram-negative bacteria,and early and sufficient use of carbapenems,glycopeptides,and nitroimidazoles can achieve a higher coverage rate of pathogenic bacteria. Pathogenic bacteria tend to have a low sensitivity to common antibiotics,and there are increases in the types and numbers of drug-resistant strains compared with previous reports,suggesting that the use of antibiotics should be standardized in clinical practice to reduce the production of drug-resistant strains.
Zhang JY , Xiao CF , Wang C , et al . Bibliometric insights in fournier’s gangrene:research landscapes,turning points,and global trends [J ] . Front Surg , 2023 , 10 : 1057486 .
Bowen D , Juliebø-Jones P , Somani BK . Global outcomes and lessons learned in the management of fournier’s gangrene from high-volume centres:findings from a literature review over the last two decades [J ] . World J Urol , 2022 , 40 ( 10 ): 2399 - 2410 .
Zhang KF , Shi CX , Chen SY , et al . Progress in multidisciplinary treatment of fournier’s gangrene [J ] . Infect Drug Resist , 2022 , 15 : 6869 - 6880 .
Hughes T , Bowen D , Saeed K , et al . Management of fournier’s gangrene:a practical guide for clinicians [J ] . Br J Hosp Med , 2023 , 84 ( 9 ): 1 - 9 .
Erickson BA , Flynn KJ . Management of necrotizing soft tissue infections (fournier’s gangrene) and surgical reconstruction of debridement wound defects [J ] . Urol Clin North Am , 2022 , 49 ( 3 ): 467 - 478 .
Tang LM , Su YJ , Lai YC . The evaluation of microbiology and prognosis of fournier’s gangrene in past five years [J ] . Springerplus , 2015 , 4 ( 1 ): 14 .
Misiakos EP , Bagias G , Patapis P , et al . Current concepts in the management of necrotizing fasciitis [J ] . Front Surg , 2014 , 1 : 36 .
Oyelowo N , Ahmed M , Lawal AT , et al . Fournier’s gangrene:Presentation and predictors of mortality in Zaria , Nigeria [J ] . Ann Afr Med , 2021 , 20 ( 2 ): 105 - 110 .
He XF , Xiang X , Zou Y , et al . Distinctions between fournier’s gangrene and lower extremity necrotising fasciitis:microbiology and factors affecting mortality [J ] . Int J Infect Dis , 2022 , 122 : 222 - 229 .
Koch GE , Launer BM , Li AN , et al . A disease-specific antibiogram to evaluate empiric coverage patterns in fournier’s gangrene [J ] . Urology , 2023 , 178 : 162 - 166 .
Keten T , Ozercan AY , Eroglu U , et al . Can HALP score,a new prognostic tool,take the place of traditional scoring systems in Fournier’s gangrene? [J ] . Int Urol Nephrol , 2023 , 55 ( 10 ): 2389 - 2395 .
Bjurlin MA , O’Grady T , Kim DY , et al . Causative pathogens,antibiotic sensitivity,resistance patterns,and severity in a contemporary series of Fournier’s gangrene [J ] . Urology , 2013 , 81 ( 4 ): 752 - 758 .
Peters BM , Jabra-Rizk MA , O’May GA , et al . Polymicrobial interactions:impact on pathogenesis and human disease [J ] . Clin Microbiol Rev , 2012 , 25 ( 1 ): 193 - 213 .
Srinivasan A , Sajeevan A , Rajaramon S , et al . Solving polymicrobial puzzles:evolutionary dynamics and future directions [J ] . Front Cell Infect Microbiol , 2023 , 13 : 1295063
Puia D , Gheorghincă Ş , Pricop C . The antimicrobial resistance index and fournier gangrene severity index of patients diagnosed with fournier’s gangrene in a tertiary hospital in north eastern Romania [J ] . Medicina , 2023 , 59 ( 4 ): 643 .
Tutino R , Colli F , Rizzo G , et al . Which role for hyperbaric oxygen therapy in the treatment of fournier’s gangrene?A retrospective study [J ] . Front Surg , 2022 , 9 : 850378 .
Stevens DL , Bisno AL , Chambers HF , et al . Practice guidelines for the diagnosis and management of skin and soft tissue infections:2014 update by the infectious diseases society of America [J ] . Clin Infect Dis , 2014 , 59 ( 2 ): e10-52 .
Chia L , Crum-Cianflone NF . Emergence of multi-drug resistant organisms(MDROs) causing Fournier’s gangrene [J ] . J Infect , 2018 , 76 ( 1 ): 38 - 43 .
Angelini J , Giuliano S , Flammini S , et al . Meropenem PK/PD variability and renal function:“we go together” [J ] . Pharmaceutics , 2023 , 15 ( 9 ): 2238 .
Yamaguchi R , Yamamoto T , Okamoto K , et al . Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia:a propensity score-adjusted non-inferior comparative study [J ] . J Antimicrob Chemother , 2023 , 78 ( 5 ): 1231 - 1240 .
王钱陶 , 肖长芳 , 王 琛 , 等 . 基于数据挖掘分析中医治疗老年肛周会阴部坏死性筋膜炎术后用药规律 [J ] . 老年医学与保健 , 2021 , 27 ( 2 ): 348 - 351,404 .
Wang QT , Xiao CF , Wang C , et al . Analysis of postoperative medication rule of traditional Chinese medicine in the treatment of elderly patients with perianal and perineal necrotizing fasciitis based on data mining technology [J ] . Geriatr Health Care , 2021 , 27 ( 2 ): 348 - 351,404 .
郝 爽 , 姚一博 , 孙琰婷 , 等 . 顾氏外科特色的中西医结合疗法治疗肛周坏死性筋膜炎经验 [J ] . 山东中医杂志 , 2022 , 41 ( 10 ): 1092 - 1095 .
Hao S , Yao YB , Sun YT , et al . Experience in treating perianal necrotizing fasciitis with GU’s surgery of integrated Chinese medicine and western medicine [J ] . Shandong J Tradit Chin Med , 2022 , 41 ( 10 ): 1092 - 1095 .
查翔远 , 潘晓龙 , 胡志军 , 等 . 2010—2014年血培养分离菌的分布及耐药性分析 [J ] . 中国感染与化疗杂志 , 2016 , 16 ( 5 ): 602 - 607 .
Zha XY , Pan XL , Hu ZJ , et al . The distribution and antibiotic resistance of clinical isolates from blood culture:a five-year analysis from 2010 to 2014 [J ] . Chin J Infect Chemother , 2016 , 16 ( 5 ): 602 - 607 .
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621